EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Spoonful of technology: May-June 2024

Explore the top tech stories that have shaped pharma in recent months as we explore implants to AI models, with a particular focus on antimicrobial resistance.

Spotlight: June 2024

Discover June’s top pharma news in our monthly round-up. From the latest market predictions to new vaccine development initiatives, there’s plenty to discover.

GLP-1 treatments may lower cancer risk in type 2 diabetes patients

A new study finds that patients with type 2 diabetes taking GLP-1 treatments have a reduced chance of developing obesity-related cancers.

New MS blood test to launch in Europe

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.    
The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: May 2024

Catch up on May’s top pharma news in this monthly round-up. From the latest HCP insights on pharma companies to new investments, there’s plenty to discover.
Picture of a pink illustrated brain on a mint green background

Elon Musk’s Neuralink seeks patients for clinical trial

Neuralink, Elon Musk’s brain chip company, is preparing for the first clinical trial of its implant technology.

FDA nod for Roche and Amgen’s blood testing device

The FDA has granted Breakthrough Device Designation to Roche’s new blood test, developed in collaboration with Amgen, that measures key blood markers of inherited cardiovascular risk.

GSK pledges £45m to new antimicrobial resistance initiative

GSK has pledged £45m to the Fleming Initiative, a UK scheme to tackle antimicrobial resistance, led by Imperial College Healthcare NHS Trust and Imperial College London.